Standard BioTools Inc.

NasdaqGS:LAB Stock Report

Market Cap: US$574.9m

Standard BioTools Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:LAB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Dec 25BuyUS$502,570Casdin Capital, LLCCompany350,000US$1.45
25 Nov 25BuyUS$10,053,280Casdin Capital, LLCCompany7,700,000US$1.43
20 Nov 25BuyUS$1,374,575Casdin Capital, LLCCompany1,075,000US$1.30
17 Nov 25BuyUS$1,126,775Casdin Capital, LLCCompany925,000US$1.24
12 Nov 25BuyUS$1,379,318Casdin Capital, LLCCompany1,175,000US$1.20
09 Sep 25BuyUS$128,920Casdin Capital, LLCCompany100,000US$1.29
04 Sep 25BuyUS$635,750Casdin Capital, LLCCompany500,000US$1.28
26 Aug 25BuyUS$658,798Casdin Capital, LLCCompany525,000US$1.26
15 Aug 25BuyUS$443,033Casdin Capital, LLCCompany358,220US$1.31
23 May 25SellUS$5,150Michael EgholmIndividual5,473US$0.94
23 May 25SellUS$12,437Sean MackayIndividual13,217US$0.94
23 May 25SellUS$1,344Hanjoon KimIndividual1,428US$0.94
22 May 25SellUS$25,784Sean MackayIndividual25,374US$1.03
22 May 25SellUS$5,126Michael EgholmIndividual5,116US$1.00
22 May 25SellUS$1,358Hanjoon KimIndividual1,355US$1.00
21 May 25SellUS$1,449Hanjoon KimIndividual1,407US$1.03
21 May 25SellUS$4,861Michael EgholmIndividual4,719US$1.03
28 Feb 25BuyUS$5,134,321Casdin Capital, LLCCompany4,820,959US$1.07

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LAB?
Owner TypeNumber of SharesOwnership Percentage
Public Companies16,5150.00429%
Individual Insiders5,590,0071.45%
Hedge Funds58,651,17015.3%
General Public85,992,65522.4%
VC/PE Firms88,783,85623.1%
Institutions145,531,21137.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.1%
Casdin Capital, LLC
88,783,856US$132.7m14.5%9.08%
15.3%
Viking Global Investors LP
58,651,170US$87.7m0%0.24%
6.48%
BlackRock, Inc.
24,920,918US$37.3m0.39%no data
4.48%
The Vanguard Group, Inc.
17,245,583US$25.8m1.55%no data
4.14%
MAK Capital One, LLC
15,931,806US$23.8m185%4.32%
2.95%
Long Focus Capital Management LLC
11,362,804US$17.0m12.8%1.09%
1.94%
Geode Capital Management, LLC
7,468,917US$11.2m0.37%no data
1.66%
State Street Global Advisors, Inc.
6,402,649US$9.6m1.61%no data
1.5%
Hollow Brook Wealth Management LLC
5,775,739US$8.6m2.95%2.14%
1.47%
Morgan Stanley Investment Management Inc.
5,644,019US$8.4m5.33%0.01%
1.4%
Amova Asset Management Co., Ltd.
5,391,829US$8.1m-12.6%no data
1.23%
Neuberger Berman Investment Advisers LLC
4,725,812US$7.1m4.71%0.01%
0.92%
Tikvah Management LLC
3,551,152US$5.3m-29.7%1.47%
0.83%
Barclays PLC
3,174,001US$4.7m-3.9%no data
0.79%
ARK Investment Management LLC
3,021,728US$4.5m-4.23%0.03%
0.73%
Royce & Associates, LP
2,804,719US$4.2m6.36%0.04%
0.72%
Eli Casdin
2,786,050US$4.2m1.06%no data
0.67%
Northern Trust Global Investments
2,593,910US$3.9m-2.47%no data
0.65%
Charles Schwab Investment Management, Inc.
2,504,180US$3.7m-1.48%no data
0.49%
Pivotal BioVenture Partners LLC
1,883,179US$2.8m0%0.89%
0.42%
Slate Path Capital LP
1,615,000US$2.4m0%0.03%
0.38%
Millennium Management LLC
1,453,575US$2.2m-38.4%no data
0.34%
Pacific Asset Management LLP
1,325,000US$2.0m-3.64%0.17%
0.28%
The Goldman Sachs Group, Inc.
1,088,071US$1.6m-10.8%no data
0.27%
Michael Egholm
1,027,316US$1.5m7.68%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/24 16:40
End of Day Share Price 2025/12/23 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Standard BioTools Inc. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sung Ji NamBTIG
Bryan BrokmeierCantor Fitzgerald & Co.
Shawn BevecDeutsche Bank